サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1497579

犬アトピー性皮膚炎市場：製品、アレルゲン、投与経路、流通チャネル、エンドユーザー別- 世界予測2024-2030年

Canine Atopic Dermatitis Market by Product (Antihistamines, Glucocorticoids, Immunosuppressants), Allergen (Dander, Microorganisms, Mites), Route of Administration, Distribution Channel, End-User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 190 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=153.16円
犬アトピー性皮膚炎市場：製品、アレルゲン、投与経路、流通チャネル、エンドユーザー別- 世界予測2024-2030年
出版日: 2024年06月05日
発行: 360iResearch
ページ情報: 英文 190 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

犬アトピー性皮膚炎市場規模は2023年に15億7,000万米ドルと推計され、2024年には16億9,000万米ドルに達し、CAGR 8.40％で2030年には27億6,000万米ドルに達すると予測されています。

犬アトピー性皮膚炎（CAD）は、異常な免疫反応や環境アレルゲンに対する先天的な素因による、犬の慢性的なそう痒性炎症性皮膚疾患です。ライフスタイルの変化に伴う犬の飼育率の増加や、ペットの健康管理に対する意識の高まりにより、世界中でCADの治療が行われるようになった。近年、診断技術の進歩により、この慢性疾患に対する効果的な治療法が確立されつつあります。しかし、診断や長期管理に伴う高額な費用が飼い主の障壁となり、新たな治療や療法の導入が制限されることもあります。犬アトピー性皮膚炎市場では、規制上のハードルが新規治療薬の開発と認可の妨げになる可能性があります。企業は、多様なCAD治療の商業化を確実にするため、変化する規制の知識を確保しながら、費用対効果の高い治療を提供する革新的な調査に取り組んでいます。次世代シークエンシング（NGS）などの新たな技術は、犬アトピー性皮膚炎の感受性や治療反応性に寄与する遺伝的要因を特定するのに役立ち、個別化治療のアプローチに貴重な情報を提供します。

主な市場の統計
基準年［2023] 15億7,000万米ドル
予測年［2024] 16億9,000万米ドル
予測年 [2030] 27億6,000万米ドル
CAGR（%） 8.40%

地域別インサイト

南北アメリカのCAD市場は、獣医学における大きな市場開拓と、新世代の治療法を提供するための既存企業による継続的な研究活動により、進展しています。米国とカナダでは、CADがペットのQOLに与える影響を認識する飼い主が増えており、同地域では効果的な治療に対する需要が急増しています。CADの有病率はアジア諸国、特に都市化した地域で著しく上昇しています。しかし、獣医皮膚科学に関する認知度は低く、市場構造も断片的であるため、この地域に進出する企業にとっては課題となっています。大手世界企業はアジアで存在感を示しているが、CAD治療に費用対効果の高い選択肢を提供する地元の中小メーカーと競合する必要があります。欧州市場は動物用皮膚科の成熟した市場であり、CADを管理するための専門的な診断ツールや治療ソリューションを提供する老舗企業によって特徴づけられています。大手製薬企業間の提携により、アトピー性皮膚炎に伴うそう痒症を緩和する画期的なモノクローナル抗体療法が開発されています。

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスは、犬アトピー性皮膚炎市場におけるベンダーのポジショニングを評価する上で不可欠です。このマトリックスはベンダーの包括的な評価を提供し、事業戦略や製品満足度に関連する重要な指標を検証します。この詳細な評価により、ユーザーは自らの要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功のレベルを表す4つの象限、すなわちForefront（F）、Pathfinder（P）、Niche（N）、Vital（V）に分類されます。

市場シェア分析

市場シェア分析は、犬アトピー性皮膚炎市場におけるベンダーの現状について、洞察に満ちた詳細な評価を提供する包括的なツールです。ベンダーの貢献度を綿密に比較・分析することで、各ベンダーの業績や市場シェア争いの際に直面する課題について、より深い理解を得ることができます。これらの貢献には、全体的な収益、顧客ベース、その他の重要な指標が含まれます。さらに、この分析では、調査した基準年の期間に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合性に関する貴重な考察を提供しています。このような詳細な情報を得ることで、ベンダーは市場競争において優位に立つために、より多くの情報に基づいた意思決定を行い、効果的な戦略を考案することができます。

戦略分析と推奨

戦略分析は、世界マーケットで確固たる足場を築こうとする組織にとって不可欠です。企業は、犬アトピー性皮膚炎市場における現在の地位を徹底的に評価することで、長期的な願望に沿った情報に基づいた意思決定を行うことができます。この重要な評価には、組織のリソース、能力、全体的なパフォーマンスを徹底的に分析し、中核となる強みと改善すべき領域を特定することが含まれます。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • ペット飼育数の増加と犬のアレルゲンに関連する汚染の増加
      • 天然成分や非薬理学的方法への注目が高まる
    • 抑制要因
      • ペットにおける適応外医薬品の使用増加
    • 機会
      • 犬アトピー性皮膚炎（CAD）のR&D投資製品発売の増加
      • ペット保険の継続的な需要とペット所有者の懸念の高まり
    • 課題
      • CADの複雑な病因と治療の有効性と安全性に関する懸念
  • 市場セグメンテーション分析
    • 製品：CADの効果的な治療のための抗ヒスタミン薬とグルココルチコイドの使用拡大
    • アレルゲン：ダニや微小な寄生虫がCADの主な原因である
    • 投与経路：注射剤と経口剤が最も好ましい投与方法である
    • 流通チャネル：オンライン流通チャネルを通じたCAD医薬品の新たな入手可能性
    • エンドユーザー：診療所におけるCAD診断の増加と効果的な治療の必要性
  • 市場ディスラプション分析
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 価格分析
  • 技術分析
  • 特許分析
  • 貿易分析
  • 規制枠組みの分析

第6章 犬アトピー性皮膚炎市場：製品別

  • 抗ヒスタミン薬
  • グルココルチコイド
  • 免疫抑制剤
  • モノクローナル抗体

第7章 犬アトピー性皮膚炎市場アレルゲン

  • ふけ
  • 微生物
  • ダニ
  • 花粉

第8章 犬アトピー性皮膚炎市場：投与経路別

  • 注射可能
  • オーラル
  • 話題

第9章 犬アトピー性皮膚炎市場：流通チャネル別

  • 病院・クリニック
  • オンライン
  • 小売獣医

第10章 犬アトピー性皮膚炎市場：エンドユーザー別

  • 病院
  • 獣医クリニック

第11章 南北アメリカの犬アトピー性皮膚炎市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第12章 アジア太平洋地域の犬アトピー性皮膚炎市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第13章 欧州・中東・アフリカの犬アトピー性皮膚炎市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第14章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
    • ゾエティス、米国ネブラスカ州リンカーンに最新鋭の施設を開設
    • ゾエティス社、アレルギー性皮膚炎に伴う掻痒の抑制および犬のアトピー性皮膚炎の抑制を目的としたアポクエルチュアブル（オクラシチニブチュアブル錠）のFDA承認を発表
    • ILCセラピューティクスはデクラ・ファーマシューティカルズと戦略的研究開発提携を締結
    • ビオイベリカ、脂質ベースのバイオスフェーン成分を使用したアトピー性皮膚炎用の犬・猫用首輪を発売
    • ロイヤルカナン北米、犬アトピー性皮膚炎の管理に役立つSKINTOPICの発売を発表
  • 戦略分析と提言

第15章 競合ポートフォリオ

  • 主要企業プロファイル
  • 主要製品ポートフォリオ
図表

LIST OF FIGURES

  • FIGURE 1. CANINE ATOPIC DERMATITIS MARKET RESEARCH PROCESS
  • FIGURE 2. CANINE ATOPIC DERMATITIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CANINE ATOPIC DERMATITIS MARKET DYNAMICS
  • FIGURE 7. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. CANINE ATOPIC DERMATITIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. CANINE ATOPIC DERMATITIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CANINE ATOPIC DERMATITIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DANDER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DANDER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY MICROORGANISMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY MICROORGANISMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY MITES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY MITES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY POLLEN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY POLLEN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY INJECTABLE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ONLINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ONLINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY RETAIL VETERINARY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY RETAIL VETERINARY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY VETERNARY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY VETERNARY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 71. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 72. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 81. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 82. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 83. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2023 (USD MILLION)
  • TABLE 84. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2024-2030 (USD MILLION)
  • TABLE 85. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 86. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 89. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 90. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 91. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 92. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 93. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2023 (USD MILLION)
  • TABLE 94. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2024-2030 (USD MILLION)
  • TABLE 95. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 96. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 97. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 98. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 99. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 100. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 101. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 102. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2024-2030 (USD MILLION)
  • TABLE 105. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 106. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 109. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 110. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 111. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 112. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2024-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 126. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2023 (USD MILLION)
  • TABLE 128. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2024-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 130. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 132. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 134. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 135. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 136. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 137. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2023 (USD MILLION)
  • TABLE 138. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2024-2030 (USD MILLION)
  • TABLE 139. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 140. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 141. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 142. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 143. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 144. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 145. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 146. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 147. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2023 (USD MILLION)
  • TABLE 148. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2024-2030 (USD MILLION)
  • TABLE 149. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 150. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 151. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 152. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 153. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 154. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 155. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 156. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 157. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2023 (USD MILLION)
  • TABLE 158. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2024-2030 (USD MILLION)
  • TABLE 159. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 160. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 161. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 162. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 163. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 164. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 165. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 166. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 167. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2023 (USD MILLION)
  • TABLE 168. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2024-2030 (USD MILLION)
  • TABLE 169. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 170. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 171. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 172. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 173. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 174. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 175. MALAYSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 176. MALAYSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 177. MALAYSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2023 (USD MILLION)
  • TABLE 178. MALAYSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2024-2030 (USD MILLION)
  • TABLE 179. MALAYSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 180. MALAYSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 181. MALAYSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 182. MALAYSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 183. MALAYSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 184. MALAYSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 186. PHILIPPINES CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2023 (USD MILLION)
  • TABLE 188. PHILIPPINES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2024-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 190. PHILIPPINES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 192. PHILIPPINES CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 193. PHILIPPINES CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 194. PHILIPPINES CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 195. SINGAPORE CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 196. SINGAPORE CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 197. SINGAPORE CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2023 (USD MILLION)
  • TABLE 198. SINGAPORE CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2024-2030 (USD MILLION)
  • TABLE 199. SINGAPORE CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 200. SINGAPORE CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 201. SINGAPORE CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 202. SINGAPORE CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 203. SINGAPORE CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 204. SINGAPORE CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 206. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2023 (USD MILLION)
  • TABLE 208. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2024-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 210. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 211. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 212. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 213. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 214. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 215. TAIWAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 216. TAIWAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 217. TAIWAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2023 (USD MILLION)
  • TABLE 218. TAIWAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2024-2030 (USD MILLION)
  • TABLE 219. TAIWAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 220. TAIWAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 221. TAIWAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 222. TAIWAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 223. TAIWAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 224. TAIWAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 225. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 226. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 227. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2023 (USD MILLION)
  • TABLE 228. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2024-2030 (USD MILLION)
  • TABLE 229. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 230. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 231. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 232. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 233. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 234. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 235. VIETNAM CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 236. VIETNAM CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 237. VIETNAM CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2023 (USD MILLION)
  • TABLE 238. VIETNAM CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2024-2030 (USD MILLION)
  • TABLE 239. VIETNAM CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 240. VIETNAM CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 241. VIETNAM CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 242. VIETNAM CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 243. VIETNAM CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 244. VIETNAM CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2024-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 257. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 258. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 259. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2023 (USD MILLION)
  • TABLE 260. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2024-2030 (USD MILLION)
  • TABLE 261. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 262. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 263. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 264. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 265. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 266. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 267. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 268. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 269. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2023 (USD MILLION)
  • TABLE 270. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2024-2030 (USD MILLION)
  • TABLE 271. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 272. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 273. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 274. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 275. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 276. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 277. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 278. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 279. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2023 (USD MILLION)
  • TABLE 280. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2024-2030 (USD MILLION)
  • TABLE 281. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 282. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 283. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 284. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 285. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 286. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 287. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 288. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 289. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2023 (USD MILLION)
  • TABLE 290. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2024-2030 (USD MILLION)
  • TABLE 291. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 292. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 293. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 294. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 295. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 296. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 297. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 298. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 299. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2023 (USD MILLION)
  • TABLE 300. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2024-2030 (USD MILLION)
  • TABLE 301. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 302. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 303. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 304. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 305. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 306. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 307. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 308. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 309. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2023 (USD MILLION)
  • TABLE 310. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2024-2030 (USD MILLION)
  • TABLE 311. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 312. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 313. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 314. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 315. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 316. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 317. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 318. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 319. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2018-2023 (USD MILLION)
  • TABLE 320. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ALLERGEN, 2024-2030 (USD MILLION)
  • TABLE 321. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 322. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 323. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 324. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 325. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 326. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 327. NETHERLANDS CANINE ATOPIC
目次
Product Code: MRR-A339DAEFA20E

[190 Pages Report] The Canine Atopic Dermatitis Market size was estimated at USD 1.57 billion in 2023 and expected to reach USD 1.69 billion in 2024, at a CAGR 8.40% to reach USD 2.76 billion by 2030.

Canine atopic dermatitis (CAD) is a chronic, pruritic inflammatory skin condition in dogs due to an inherited predisposition to aberrant immune responses and environmental allergens. Increasing dog ownership rates with changing lifestyles and greater awareness about pet healthcare have led to the adoption of CAD treatments worldwide. Recent years have observed advancements in diagnostic techniques, enabling effective treatment solutions for this chronic condition. However, high costs associated with diagnostics and long-term management can also be a barrier for pet owners, limiting the adoption of new treatments and therapies. Regulatory hurdles can impede the development and approval of novel therapeutics in the canine atopic dermatitis market. Companies are working on innovative research to offer cost-effective treatments while ensuring knowledge of the changing regulations to ensure the commercialization of diverse CAD treatments. Emerging technologies such as next-generation sequencing (NGS) could help identify genetic factors contributing to canine atopic dermatitis susceptibility or treatment response, providing valuable information for personalized therapy approaches.

KEY MARKET STATISTICS
Base Year [2023] USD 1.57 billion
Estimated Year [2024] USD 1.69 billion
Forecast Year [2030] USD 2.76 billion
CAGR (%) 8.40%

Regional Insights

The Americas CAD market is advancing, driven by huge developments in veterinary medicine and ongoing research activities by established companies to offer new-generation treatments. With an increasing number of pet owners becoming aware of CAD's impact on their pets' quality of life in the U.S. and Canada, demand for effective treatments has surged in the region. The prevalence of CAD is significantly rising across Asian countries, particularly in urbanized regions. However, limited awareness about veterinary dermatology and fragmented market structures present challenges to companies catering to this region. Major global players have established a presence in Asia; however they need to contend with smaller local manufacturers that offer cost-effective alternatives for CAD treatments. The European market presents a mature landscape for veterinary dermatology, characterized by well-established companies offering specialized diagnostic tools and therapeutic solutions for managing CAD. Partnerships between leading pharmaceutical firms have led to the development of innovative monoclonal antibody therapies, which offer targeted relief from pruritus associated with atopic dermatitis.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Canine Atopic Dermatitis Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Increasing number of pet ownership and rising pollution related to allergens on dogs
      • Rising focus on natural ingredients or non-pharmacological methods
    • Market Restraints
      • Increasing use of off-label drugs among pets
    • Market Opportunities
      • Rise in the R&D investments product launches for canine atopic dermatitis (CAD)
      • Ongoing demand for pet insurance and rising concerns among pet owners
    • Market Challenges
      • Complex etiology of CAD & concerns over treatment efficacy and safety
  • Market Segmentation Analysis
    • Product: Expanding use of antihistamines and glucocorticoids for effective treatment of CAD
    • Allergen: Dust mites and microscopic parasites prevail as the major cause of CAD
    • Route of Administration: Injectables and orals to be the most preferred mode of medication application
    • Distribution Channel: Emerging availability of CAD medications through online distribution channels
    • End-User: Increasing CAD diagnosis in clinics and need for effective treatments
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Canine Atopic Dermatitis Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Canine Atopic Dermatitis Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Zoetis Opens New State-of-the-Art Facility in Lincoln, NE, USA

Zoetis conducted the opening of its state-of-the-art mAbs expansion facility in Lincoln, Nebraska, and the facility comprises manufacturing, testing, and support buildings, employing a dedicated workforce of nearly 950 employees who work around the clock year-round. The facility is responsible for the production of animal health biologics, biopharmaceuticals, and pharmaceutical products tailoring to meet the specific needs of animals. [Published On: 2023-08-09]

Zoetis Announces FDA Approval of Apoquel Chewable (oclacitinib chewable tablet) for Control of Pruritus Associated With Allergic Dermatitis and Control of Atopic Dermatitis in Dogs

Zoetis Inc. announced that the FDA approved Apoquel chewable tablet for controlling pruritus associated with allergic dermatitis and atopic dermatitis in dogs aged 12 months and above. This chewable treatment is the first of its kind in the U.S., offering comparable efficacy to the original Apoquel (oclacitinib tablet). [Published On: 2023-06-13]

ILC Therapeutics entered into a strategic R&D partnership with Dechra Pharmaceuticals

UK-based biotech company ILC Therapeutics announced a research and development partnership with Dechra Pharmaceuticals. The collaboration aims to develop ILC's Caniferon product to treat canine atopic dermatitis. This collaboration contributes to their existing pipeline and may lead to a full development program and can enable the effective development of an effective treatment for canine atopic dermatitis. [Published On: 2023-05-24]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Canine Atopic Dermatitis Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Canine Atopic Dermatitis Market, highlighting leading vendors and their innovative profiles. These include AB Science SA, AbbVie, Inc., Agrolabo SpA, Bimeda, Inc., Bioceltix JSC, Bioiberica S.A.U., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Deep Marine Collagen, Elanco Animal Health Incorporated, Farnam Companies, Inc., IDEXX Laboratories, Inc., Incyte Corporation, Kemin Industries, Inc., LEO Pharma A/S, Merck & Co. Inc., Natural Dog Company, Nextmune, Nippon Zenyaku Kogyo Co., Ltd., Novartis AG, Ourofino Animal Health, Pfizer Inc, Phibro Animal Health Corporation, Regeneron Pharmaceuticals, Inc, Saiba Animal Health AG, Toray Industries Inc., Vetoquinol S.A., Virbac Corporation, Zinpro Corporation, Zoetis Inc., and Zymox by Pet King Brands LLC.

Market Segmentation & Coverage

This research report categorizes the Canine Atopic Dermatitis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Antihistamines
    • Glucocorticoids
    • Immunosuppressants
    • Monoclonal Antibodies
  • Allergen
    • Dander
    • Microorganisms
    • Mites
    • Pollen
  • Route of Administration
    • Injectable
    • Oral
    • Topical
  • Distribution Channel
    • Hospitals & Clinics
    • Online
    • Retail Veterinary
  • End-User
    • Hospitals
    • Veternary Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of pet ownership and rising pollution related to allergens on dogs
      • 5.1.1.2. Rising focus on natural ingredients or non-pharmacological methods
    • 5.1.2. Restraints
      • 5.1.2.1. Increasing use of off-label drugs among pets
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise in the R&D investments product launches for canine atopic dermatitis (CAD)
      • 5.1.3.2. Ongoing demand for pet insurance and rising concerns among pet owners
    • 5.1.4. Challenges
      • 5.1.4.1. Complex etiology of CAD & concerns over treatment efficacy and safety
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Expanding use of antihistamines and glucocorticoids for effective treatment of CAD
    • 5.2.2. Allergen: Dust mites and microscopic parasites prevail as the major cause of CAD
    • 5.2.3. Route of Administration: Injectables and orals to be the most preferred mode of medication application
    • 5.2.4. Distribution Channel: Emerging availability of CAD medications through online distribution channels
    • 5.2.5. End-User: Increasing CAD diagnosis in clinics and need for effective treatments
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Canine Atopic Dermatitis Market, by Product

  • 6.1. Introduction
  • 6.2. Antihistamines
  • 6.3. Glucocorticoids
  • 6.4. Immunosuppressants
  • 6.5. Monoclonal Antibodies

7. Canine Atopic Dermatitis Market, by Allergen

  • 7.1. Introduction
  • 7.2. Dander
  • 7.3. Microorganisms
  • 7.4. Mites
  • 7.5. Pollen

8. Canine Atopic Dermatitis Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Injectable
  • 8.3. Oral
  • 8.4. Topical

9. Canine Atopic Dermatitis Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospitals & Clinics
  • 9.3. Online
  • 9.4. Retail Veterinary

10. Canine Atopic Dermatitis Market, by End-User

  • 10.1. Introduction
  • 10.2. Hospitals
  • 10.3. Veternary Clinics

11. Americas Canine Atopic Dermatitis Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Canine Atopic Dermatitis Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Canine Atopic Dermatitis Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Zoetis Opens New State-of-the-Art Facility in Lincoln, NE, USA
    • 14.3.2. Zoetis Announces FDA Approval of Apoquel Chewable (oclacitinib chewable tablet) for Control of Pruritus Associated With Allergic Dermatitis and Control of Atopic Dermatitis in Dogs
    • 14.3.3. ILC Therapeutics entered into a strategic R&D partnership with Dechra Pharmaceuticals
    • 14.3.4. Bioiberica Launches Dog And Cat Collar For Atopic Dermatitis Featuring Company's Lipids-Based Biosfeen Ingredient
    • 14.3.5. Royal Canin North America Announces Launch of SKINTOPIC to Help in the Management of Canine Atopic Dermatitis
  • 14.4. Strategy Analysis & Recommendation

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio